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1. Introduction 
Amide-Aldehyde-Dienophile (AAD) reaction is a well-known 
multicomponent reaction introduced by Beller and co-workers in 
2001 (Scheme 1).1 Since then, Beller’s group have been 
expanding the scope of this multicomponent AAD reaction using 
different dienophiles, several substituted α,β-unsaturated 
aldehydes and different lineal or cyclic amides 1, obtaining in all 
cases only the ndo-approach of the Diels-Alder reaction in the 
racemic version (Scheme 1).2 The same group performed the 
chiral version of the same reaction introducing a stereocenter in 
the amide 1, using for that purpose substituted lactams. This 
reagent, in combination with different aldehydes anddienophiles 
yield enantioenriched endo-products 2 as major diastereoisomer 
in the AAD reaction.3 
 
Scheme 1. Multicomponent reaction of the general Amide-
Aldehyde-Dienophile (AAD). 
The N-cyclohex-2-en-1-amide scaffold 2 is a unit present in 
the somatostatin analogues and the group of Kessler applied 
conveniently this reaction to achieve the desired product.4 
Beller's group also applied this reaction to synthetize 
corollosporine analogues to test their antimicrobial activity.5 The 
employment of an amine instead of the amide in this reaction is 
less known and less favoured, being necessary the use of quite 
reactive reagents to carry out the reaction. Few works have been 
reported using a multicomponent Amine-Aldehyde-Dienophile 
(AAD) reaction to obtain a cyclohex-2-en-1-amine skeleton 4. 
Thus, in 2014, Weber and co-workers6 performed the AAD 
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reaction with pyrrolidine 3a, different substituted α,β-
unsaturated aldehydes and only nitrostyrenes as dienophiles 
(Scheme 2a). In contrast, the group of Sherburn7 introduce 
different dienophiles, morpholine, but just working with one 
aldehyde 5 which is a very reactive aldehyde obtaining high to 
excellent yields (Scheme 2b). In this work only one example with 
benzylamine was reported. More recently, our group introduced 
an AAD reaction with chiral nitroprolinate 3c obtaining the 
enantiopure endo-diastereoisomers 4c as exclusive product in the 
crude mixture with excellent yields after purification (Scheme 
2c).8 In this multicomponent reaction, it was possible to induce 
the absolute configuration of three new stereogenic centers in a 
single reaction step. In fact, this mechanism is the basic 




Scheme 2. a) Multicomponent AAD sequence employing the 
secondary amine 3a. b) Multicomponent AAD process employing 
the aldehyde 5. c) Full diasteresoselective AAD reaction employing 
enantiomerically enriched nitroprolinate 3c. 
 
According to these precedents, pyrrolidine derivatives and 
morpholines cannot be transformed in amines whilst 
sulfonamides and amides required so hard hydrolysis conditions 
that many functional groups of the molecule (for example, 
succinimides) can be hydrolysed too.10 So, the evaluation of 
primary amines, such as benzylamine and p-
methoxybenzylamine, which can be easily transformed in the 
corresponding primary amines, using alternative methodologies 
to the classical hydrolysis, is the main goal of this work. Also, 
the publication of a family of antibacterial agents 3-
aminocyclohexenes11 encourage us to study the scope this 
multicomponent AmineAD. 
 
2. Results and Discussion 
The model reaction employed for the optimization of this 
multicomponent AAD involved benzylamine, crotonaldehyde 
and N-methylmaleimide (NMM) as dienophile (Scheme 3). 
Toluene was selected as solvent due to the good results obtained 
in our group.8 Only two parameters, the temperature and the 
nature of some additives were evaluated (Table 1) for the 
generation of compound 6a. When the reaction was carried out 
without additives at room temperature for 16 h only Michael 
addition products were observed (Table 1, entry 1). However, the 
increment of the temperature favored the AAD reaction (Table 1, 
entries 2-3) obtaining complex crude products (1H NMR). Next, 
the addition of p-toluenesulfonic acid as additive was tested 
obtaining only the Michael-type compounds at the end of the 
reaction (Table 1, entry 4). On the other hand, benzoic acid at 70 
°C gave better results than when the reaction was carry out 
without additive at the same temperature (Table 1, entry 5). With 
the idea of working with a masked secondary amine derived from 
benzylamine, we used trimethylsilyl chloride and trimethylamine 
in several proportions for the in situ generation of 
trimethylsilylbenzylamine (Table 1, entries 6-12). The use of 
TMSCl (30% mol) gave a high conversion and a very complex 
reaction crude for 6a (Table 1, entry 6). The combination 
TMSCl/Et3N (30% mol, each) afforded cleaner crude mixtures 
(Table 1, entry 7). When 1 equiv of both additives were tested the 
yield increased to 76% (Table 1, entry 8). Surprisingly, using a 
sequential mode of the reaction, mixing benzylamine, 
trimethylsilyl chloride and triethylamine in toluen, and after 30 
min adding crotonaldehyde and N-methylmaleimide, the best 
yield was obtained (Table 1, entry 9). No significative differences 
were observed when the temperature was raised, in contrast, the 
reaction conversion was lower when the temperature decreased to 
50 °C (Table 1, entries 10 and 11, respectively). Taking into 
consideration the work of Sherburn,7 chloroform was select as 
solvent obtaining lower chemical yields but with clean r crude 
reaction mixture (Table 1, entry 12). Complete conversion was 
detected when triethylamine was added without trimethylsilyl 
chloride (Table 1, entry 13), demonstrating that the presence of 
the base is critical for the reaction to take place (Table 1, entry 
14). At this point, the time of the reaction was contr lled 
observing that the reaction was completed in only 1.5 h in 
chloroform and also in toluene (Table 1, entries 15 and 16).  
 
 
Scheme 3. Multicomponent AAD synthesis of product 6a. 
 
Table 1. Optimization of the reaction conditions to synthetiz  
cyclohex-2-en-1-amine 6a via AAD reaction. 






1 --- PhCH3 25 16 0 
2 --- PhCH3 70 16 48 
3 --- PhCH3 110 16 72 
4 p-TsOH (30%) PhCH3 70 16 0 
5 BzOH (30%) PhCH3 70 16 65 
6 ClSiMe3 (30%) PhCH3 70 16 63 
7 
ClSiMe3 (30%), Et3N 
(30%) 
PhCH3 70 16 69 
8 
ClSiMe3 (100%), Et3N 
(100%) 
PhCH3 70 16 76 
9b 
ClSiMe3 (100%), Et3N 
(100%) 
PhCH3 70 16 87 
10b 
ClSiMe3 (100%), Et3N 
(100%) 
PhCH3 110 16 88 
















ClSiMe3 (100%), Et3N 
(100%) 
CHCl3 70 16 25 
13 Et3N (100%) CHCl3 70 16 >95 
14 --- CHCl3 70 16 0 
15 Et3N (100%) CHCl3 70 1.5 >95 
16 Et3N (100%) PhMe 70 1.5 89 
a Isolated yields after flash chromatography. b Sequential 
reaction: benzylamine, trimethylsilyl chloride and triethylamine 
reacted during 30 min at rt, then crotonaldehyde and NMM was 
added and stirring continued 16 h at the selected temperature. 
 
With this optimal conditions in hand, the amine, the aldehyde 
and the dipolarophile were mixed in chloroform at 70 °C in the 
presence of triethylamine to assess the scope of the AAD reaction 
(Scheme 4). Crotonaldehyde and benzylamine were allowed to 
react with maleimides (NMM and NBM) obtaining only one 
stereoisomer (6a and 6b, respectively) in the crude mixture in 
good isolated yields after purification (68% and 61%, 
respectively, Scheme 4). Fluorinated maleimide12 was also 
employed in this reaction obtaining the corresponding products 
6c in 51% yield (Scheme 4). Other aldehyde such as E-2-pentenal 
was assayed with N-phenylmaleimide (NPM) yielding product 
6d in 50%. 3-Methylcrotonaldehyde was also tried in this 
reaction with NPM and NBM obtaining, in both cases, almost 
only one diastereoisomer of 6e and 6f, in moderate isolated 
yields after purification (65% and 40%, respectively, Scheme 4). 
Apart from benzylamine, aliphatic primary amines such as 
butylamine or allylamine failed in this reaction, however other 
benzylamine derivative as p-methoxybenzylamine was well 
tolerated. For example, PMBNH2 was allowed to react with 
crotonaldehyde and two different maleimides obtaining 6g and 
6h with moderate to good isolated yields (42% and 39%, 
respectively). Interestingly, the pseudo-steroidal tetracyclic 
product 6i was isolated, from the corresponding aldehyde,13 in 
56% yield. The relative configuration of all molecules 6 was 
confirmed by nOe experiments and by comparison of chemical 
shifts (1H NMR). Compounds 6b, 6c, 6d, 6e, 6f and 6h were 
isolated with very small amounts of other diasteroisomer, which 
was very difficult to separate by column chromatography (see 
SI).The AAD reaction with fumarates, maleic anhydride, 
acrylates, vinylic sulfones, chalcone derivatives, nitroalkenes, 
etc., completely failed. In some examples, complex crude 
reaction mixtures were obtained isolating the expected product in 




Scheme 4. Synthesis of cyclohex-2-en-1-amines 6 via AAD 
reaction. 
 
The diastereoselective version of this AAD transformation 
was also examined (Scheme 4 and Figure 1). Using the low st 
temperature (70 ºC) and shorter reaction times (1.5h), chiral 
benzylamines were first tried in order to obtain enantiopure 
diastereoisomers. (R)-α-Methylbenzylamine was reacted with 
crotonaldehyde and NPM giving a 85:15 mixture of two 
diastereoisomers in the crude of the reaction (1H NMR) isolating 
only the major product 6j after purification in good yield (53%). 
(R)-1-(1-Naphthyl)ethylamine was also attempted obtaining in 
this example an almost equimolar diastereomeric ratio for 
products 6k and 6k’ was identified. In both cases, nOe results 
indicated the general ll-cis arrangement observed in this survey. 
When the chiral information was anchored to the malei ide, the 
diastereoselectivity was higher than in the two previous examples 
run with chrial benzylic amines. Molecule 6l was generated in 
52% yield as a 95:5 diastereomeric ratio when (R)-N-(1-
phenylethyl)maleimide was employed as enantiomerically 
















Figure 1. Synthesis of enantiomerically enriched cyclohex-2-
en-1-amines 6j-l via AAD reaction. 
 
The proposed absolute configuration of compound 6j, drawn 
in Figure 1, was confirmed by vibrational circular dichroism 
(VCD) analysis (Figure 2). Fortunately, both diastereoisomers 6j 
and 6j’  exhibited opposite theoretical VCD patterns, which was 
more relevant in the carbonyl absorption area. The experimental 
VCD (dots) and the resulting fitting line matched perfectly 
(Figure 2) with the theoretical data provided for diastereoisomer 
6j. Every maximum of the experimental absorption plot (1720 
and 1785 cm-1) is composed by the sum of two closed bands, 
possibly due to the formation of intramolecular hydrogen bonds 
between the NH and the closer carbonyl group.14 This interaction 
was also supported by the all-cis relative configuration of this 




Figure 2. VCD analysis of product 6j. Blue dashed line 
corresponds to theoretical VCD calculated with a B3LYP/6-
311G+(2d,2p) level for configuration 6j. Red dashed line 
corresponds to theoretical VCD calculated with a B3LYP/6-
311G+(2d,2p) level for the minor diastereoisomer 6j’ . Black 
curve corresponds to experimental VCD. 
 
 
The assignment of the absolute configuration for comp und 
6l was more complicated. The initial X-ray diffraction a alysis of 
a monocrystal revealed that the two enantiomers of 6l were 
symmetrically arranged in the unit cell together with wo 
molecules of hydrogen chloride.15 This crystallization occurred in 
the solution of the sample prepared for the analysis of its VCD 
experiment (Figure 3). Despite of a displacement of the 
experimental carbonyl band with respect to the calcul ted ones, 
the small absorbance at around 1450 cm-1 (C-N absorbance) also 
confirmed the drawn stereochemistry of 6l in Figure 1. It is 
important to remark that calculated conformations for both 
cycloadducts 6j and 6l revealed the presence of strong hydrogen 
bonds (2.53-2.56 Å in solid state of both enantiomers) between a 
carbonyl group of the succinimide moiety and the hydrogen atom 
of the amino group. These interactions can modify the normal 
absorbance wavelength of the carbonyls in solution and even 
avoid the detection of the NH band in 1H NMR spectroscopy (see 
SI).    
   
 
Figure 3. VCD analysis of product 6l. Blue line corresponds to 
theoretical VCD calculated with a B3LYP/6-311G+(2d,2p) level 
for configuration 6l. Red dashed line corresponds to theoretical 
VCD calculated with a B3LYP/6-311G+(2d,2p) level for the 





The preparation of polysubstituted N-benzyl and N-PMB-
cyclohex-2-eneamines has been optimized. Many aldehydes and 
maleimides can be combined with benzylamine or 4-
methoxybenzylamine in a diastereoselective multicomp nent 
process namely Amine-Aldehyde-Dienophile (AAD). Chemical 
yields are moderate to good and allow to generate all-cis relative 
configuration in the resulting final products. This sequence offers 
the possibility to remove the protecting group to achieve the free 
amino group which could not be accomplished yet. The 
introduction of a chiral information at the benzylic group of the 
benzylic amine or in the N-substituent of the maleimide gave also 
enantiomerically enriched compounds after separation by column 
chromatography. The absolute configuration of a representative 
example was determined by VCD spectroscopy. 
 
4. Experimental Section 
4.1. General 
All commercially available reagents and solvents were used 
without further purification, only aldehydes were also distilled prior 
to use. Only the aldehyde precursor of compound 6i was prepared 
according to the literature.13 Analytical TLC was performed on 
Schleicher & Schuell F1400/LS 254 silica gel plates, and the spots 
were visualized under UV light (λ = 254 nm). Flash chromatography 
was carried out on handpacked columns of Merck silica gel 60 
(0.040-0.063 mm). Melting points were determined with a Reichert 
Thermovar hot plate apparatus and are uncorrected. The structurally 
most important peaks of the IR spectra (recorded using a Nicolet 510 
P-FT) are listed and wave numbers are given in cm-1. NMR spectra 
were obtained using a Bruker AC-300 or AC-400 and were r corded 
at 300 or 400 MHz for 1H NMR and 75 or 100 MHz for 13C NMR, 
using CDCl3 as solvent and TMS as internal standard (0.00 ppm). 
The following abbreviations are used to describe peak patterns where 
appropriate: s = singlet, d = doublet, t = triplet, q = quartet, m = 














constants (J) are given in Hz and chemical shifts in ppm. 13C NMR 
spectra were referenced to CDCl3 at 77.16 ppm. DEPT-135 
experiments were performed to assign CH, CH2 and CH3. 
19F NMR 
were recorded at 282 MHz using CDCl3 as solvent. Low-resolution 
electron impact (EI) mass spectra were obtained at 70 eV using a 
Shimadzu QP-5000 by injection or DIP; fragment ions i  m/z are 
given with relative intensities (%) in parentheses. High-resolution 
mass spectra (HRMS) were measured on an instrument usi g a 
quadrupole time-of-flight mass spectrometer (QTOF) and also 
through the electron impact mode (EI) at 70 eV using a Finnigan VG 
Platform or a Finnigan MAT 95S. VCD analysis was recorded in a 
Jasco FVS-6000.   
 
4.2. General procedure for the synthesis of products 6. 
To a stirred solution of benzylamine derivative (0.25 mmol) and 
Et3N (1 equiv., 0.25 mmol) in 1 mL of toluene was adde the 
aldehyde (1 equiv., 0.25 mmol), the dienophile (1 equiv., 0.25 mmol) 
and 0.5 mL more of chloroform. The solution was stirred at 70 °C 
during 1.5 h, and after the solvent was removed under vacuum. The 
crude of the reaction was purified with flash chromatography to give 
the desired compound.  
 
4.2.1. (3aS*,4R*,7aS*)-4-(Benzylamino)-2-methyl-3a,4,7,7a-
tetrahydro-1H-isoindole-1,3(2H)-dione (6a): brown sticky oil (45.9 
mg, 68% yield). IR (neat) max: 1695, 1438, 1385, 1283, 1266, 1119, 
993, 732, 700 cm-1. 1H NMR δ: 2.07-2.17 (m, 1H, =CHCH2), 2.68 
(ddd, J = 15.5, 6.7, 2.0 Hz, 1H, =CHCH2), 2.94 (s, 3H, NCH3), 3.11 
(td, J = 8.2, 2.0 Hz, 1H, CH2CHC=O), 3.12 (br s, 1H, NH), 3.38-3.51 
(m, 2H, NCHCHC=O and NCHCH=), 3.93 (d, J = 13.0 Hz, 1H, 
NCH2Ph), 4.07 (d, J = 13.0 Hz, 1H, NCH2Ph), 5.81-5.90 (m, 1H, 
=CHCH2), 5.92-5.99 (m, 1H, NCHCH=), 7.26-7.45 (m, 5H, ArH). 
13C NMR δ: 24.1 (=CHCH2), 24.9 (NCH3), 39.3, 42.0 (2xCHC=O), 
51.4 (NCH2Ph), 53.5 (NCHCH=), 126.0, 127.5, 128.7, 132.9, 138.7 
(ArC, C=C), 178.4, 179.9 (2xC=O). MS (EI) m/z: 270 (M+, <1%), 
159 (21), 144 (35), 106 (100), 91 (71), 79 (11). HRMS calculated for 
C16H18N2O2: 270.1368; found: 270.1360. 
 
4.2.2. (3aS*,4R*,7aS*)-2-Benzyl-4-(benzylamino)-3a,4,7,7a-
tetrahydro-1H-isoindole-1,3(2H)-dione (6b): yellow prisms (52.8 
mg, 61% yield), mp 75-77 °C. IR (neat) max: 1684, 1475, 1428, 
1399, 1344, 1173, 1145, 1071, 915, 741, 699 cm-1. 1H NMR δ: 2.05-
2.18 (m, 1H, =CHCH2), 2.66 (ddd, J = 15.6, 6.7, 2.1 Hz, 1H, 
=CHCH2), 3.02 (br s, 1H, NH), 3.09 (td, J = 8.3, 2.1 Hz, 1H, 
CH2CHC=O), 3.40 (dd, J = 8.8, 6.0 Hz, 1H, NCHCHC=O), 3.45-
3.48 (m, 1H, NCHCH=), 3.89 (d, J = 13.0 Hz, 1H, CHNCH2Ph), 
4.03 (d, J = 13.0 Hz, 1H, CHNCH2Ph), 4.60 (s, 2H, O=CNCH2Ph), 
5.78-5.85 (m, 1H, =CHCH2), 5.93 (dt, J = 9.5, 3.1 Hz, 1H, 
NCHCH=), 7.23-7.41 (m, 10H, ArH). 13C NMR δ: 24.2 (=CHCH2), 
39.3, 42.0 (2xCHC=O), 42.4 (O=CNCH2Ph), 51.3 (CHNCH2Ph), 
53.5 (NCHCH=), 127.3, 127.9, 128.4, 128.5, 128.6, 128.7, 128.9, 
133.6, 135.7, 139.4 (ArC, C=C), 178.0, 179.6 (2xC=O). MS (EI) 
m/z: 346 (M+, 1%), 159 (24), 144 (26), 106 (100), 91 (66). HRMS 
calculated for C22H22N2O2: 346.1681; found: 346.1661. 
 
4.2.3. (3aS*,4R*,7aS*)-4-(Benzylamino)-2-(4-fluorobenzyl)-
3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6c): dark yellow 
sticky oil (46.5 mg, 51% yield). IR (neat) max: 1691, 1509, 1397, 
1342, 1222, 1158, 1098, 910, 737, 699 cm-1. 1H NMR δ: 2.05-2.19 
(m, 1H, =CHCH2), 2.58 (br s, 1H, NH), 2.65 (ddd, J = 15.7, 6.6, 
2.2 Hz, 1H, =CHCH2), 3.08 (td, J = 8.3, 2.2 Hz, 1H, CH2CHC=O), 
3.36 (dd, J = 8.4, 6.0 Hz, 1H, NCHCHC=O), 3.40-3.49 (m, 1H, 
NCHCH=), 3.86 (d, J = 13.0 Hz, 1H, CHNCH2Ph), 4.01 (d, J = 13.0 
Hz, 1H, CHNCH2Ph), 4.56 (s, 2H, O=CNCH2Ar), 5.74-5.85 (m, 1H, 
=CHCH2), 5.90 (dt, J = 9.5, 3.0 Hz, 1H, NCHCH=), 6.90-6.98 (m, 
2H, ArH), 7.24-7.39 (m, 7H, ArH). 13C NMR δ: 24.1 (=CHCH2), 
39.3, 41.7 (2xCHC=O), 42.1 (O=CNCH2Ar), 51.4 (CHNCH2Ph), 
53.5 (NCHCH=), 115.5 (d, 2JC-F = 21.5 Hz, CHCF), 127.1, 127.2, 
128.3, 128.5, 128.7 (ArC, C=C), 130.3 (d, 3JC-F = 8.1 Hz, CHCHCF), 
131.6 (d, 4JC-F = 3.4 Hz, CCHCHCF), 133.9, 139.8 (ArC), 162.3 (d, 
1JC-F = 246.3 Hz, CF), 177.9, 179.6 (2xC=O). 
19F NMR δ: -114.2. 
MS (EI) m/z: 364 (M+, 1%), 159 (25), 144 (27), 109 (18), 106 (100), 




3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6d): brown sticky 
oil (43.5 mg, 50% yield). IR (neat) max: 1704, 1598, 1498, 1455, 
1383, 1266, 1179, 733, 695 cm-1. 1H NMR δ: 1.44 (d, J = 7.4 Hz, 
3H, CHCH3), 2.43-2.50 (m, 1H, CHCH3), 3.14 (dd, J = 8.5, 7.1 Hz, 
1H, CH3CHCHC=O), 3.36 (br s, 1H, NH), 3.49-3.53 (m, 1H, 
NCHCH=), 3.59 (dd, J = 8.5, 6.0 Hz, 1H, NCHCHC=O), 3.92 (d, J = 
12.8 Hz, 1H, NCH2Ph), 4.10 (d, J = 12.8 Hz, 1H, NCH2Ph), 5.74 (dt, 
J = 9.3, 3.2 Hz, 1H, =CHCHCH3), 5.99 (dt, J = 9.0, 2.7 Hz, 1H, 
NCHCH=), 7.14-7.49 (m, 10H, ArH). 13C NMR δ: 16.8 (CHCH3), 
30.9 (CHCH3), 42.6, 44.5 (2xCHC=O), 51.4 (NCH2Ph), 54.5 
(NCHCH=), 126.1, 126.6, 127.3, 128.5, 128.6, 128.7, 129.2, 129.3, 
131.7, 133.1, 133.6, 139.4 (ArC, C=C), 176.3, 177.2 (2xC=O). MS 
(EI) m/z: 346 (M+, 2%), 174 (11), 173 (66), 144 (29), 106 (95), 91 




3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6e): yellow sticky 
oil (56.2 mg, 65% yield). IR (neat) max: 1705, 1499, 1442, 1386, 
1265, 1195, 1099, 1057, 732, 700 cm-1. 1H NMR δ: 1.79 (s, 3H, 
CH3), 2.21-2.33 (m, 1H, =CCH2), 2.64 (dd, J = 15.4, 2.4 Hz, 1H, 
=CCH2), 3.04 (br s, 1H, NH), 3.26 (td, J = 8.1, 2.4 Hz, 1H, 
CH2CHC=O), 3.45-3.64 (m, 2H, NCHCHC=O and NCHCH=), 3.92 
(d, J = 12.9 Hz, 1H, NCH2Ph), 4.06 (d, J = 12.9 Hz, 1H, NCH2Ph), 
5.69 (dt, J = 3.8, 2.0 Hz, 1H, NCHCH=), 7.17-7.48 (m, 10H, ArH). 
13C NMR δ: 23.3 (=CCH3), 29.7 (=CCH2), 39.1, 41.4 (2xCHC=O), 
50.7 (NCH2Ph), 53.5 (NCHCH=), 126.6, 128.9, 129.0, 129.1, 129.2, 
129.3, 130.3, 131.4, 139.7 (ArC, C=C), 177.2, 177.9 (2xC=O). MS 
(EI) m/z: 346 (M+, 7%), 345 (26), 255 (32), 241 (12) 239 (16), 173 
(17), 158 (24), 106 (49), 93 (29), 92 (15), 91 (100), 77 (18). HRMS 
calculated for C22H22N2O2: 346.1681; found: 346.1672. 
 
4.2.6. (3aS*,4R*,7aS*)-2-Benzyl-4-(benzylamino)-6-methyl-
3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6f): brown sticky 
oil (36.0 mg, 40% yield). IR (neat) max: 1692, 1431, 1399, 1344, 
1181, 1160, 910, 729, 699 cm-1. 1H NMR δ: 1.59 (s, 3H, CH3), 2.10-
2.21 (m, 1H, =CCH2), 2.64 (dd, J = 15.4, 2.1 Hz, 1H, =CCH2), 3.08 
(td, J = 8.0, 2.1 Hz, 1H, CH2CHC=O), 3.35-3.48 (m, 2H, 
NCHCHC=O and NCHCH=), 3.90 (d, J = 12.9 Hz, 1H, 
CHNCH2Ph), 4.04 (d, J = 12.9 Hz, 1H, CHNCH2Ph), 4.57 (d, J = 














Hz, 1H, O=CNCH2Ph), 5.54 (br s, 1H, NCHCH=), 7.19-7.44 (m, 
10H, ArH). 13C NMR δ: 23.0 (=CCH3), 29.4 (=CCH2), 39.3, 41.7 
(2xCHC=O), 42.5 (O=CNCH2Ph), 51.0 (CHNCH2Ph), 53.9 
(NCHCH=), 124.2, 127.7, 127.9, 128.2, 128.5, 128.6, 128.7, 128.8, 
128.9, 135.6, 137.2, 137.6 (ArC, C=C), 178.0, 179.2 (2xC=O). MS 
(EI) m/z: 360 (M+, 2%), 173 (28), 158 (45), 106 (100), 91 (73), 82 
(11). HRMS calculated for C23H24N2O2: 360.1838; found: 360.1828. 
 
4.2.7. (3aS*,4R*,7aS*)-4-[(4-Methoxybenzyl)amino]-2-methyl-
3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6g): brown sticky 
oil (31.7 mg, 42% yield). IR (neat) max: 1689, 1510, 1437, 1284, 
1245, 1118, 1033, 733, 701 cm-1. 1H NMR δ: 2.08-2.18 (m, 1H, 
=CHCH2), 2.36 (br s, 1H, NH), 2.67 (ddd, J = 15.5, 6.7, 2.1 Hz, 1H, 
=CHCH2), 2.93 (s, 3H, NCH3), 3.09 (td, J = 8.3, 2.1 Hz, 1H, 
CH2CHC=O), 3.36 (dd, J = 8.7, 6.2 Hz, 1H, NCHCHC=O), 3.40-
3.47 (m, 1H, NCHCH=), 3.80 (s, 3H, OCH3), 3.98 (d, J = 13.0 Hz, 
1H, NCH2Ar), 4.07 (d, J = 13.0 Hz, 1H, NCH2Ar), 5.81-5.87 (m, 1H, 
=CHCH2), 5.92 (dt, J = 9.5, 2.9 Hz, 1H, NCHCH=), 6.85-6.89 (m, 
2H, ArH), 7.29-7.34 (m, 2H, ArH). 13C NMR δ: 24.1 (=CHCH2), 
24.9 (NCH3), 39.4, 42.1 (2xCHC=O), 50.8 (NCH2Ar), 53.4 
(NCHCH=), 55.4 (OCH3), 114.0, 114.1, 127.0, 129.5, 129.6, 132.0, 
134.1, 158.8, (ArC, C=C), 178.4, 180.1 (2xC=O). MS (EI) m/z: 300 
(M+, 1%), 136 (100), 121 (96). HRMS calculated for C17H20N2O3: 




dione (6h): dark orange sticky oil (38.8 mg, 39% yield). IR (neat) 
max: 1698, 1510, 1433, 1398, 1343, 1247, 1223, 1173, 10 3, 733, 
699 cm-1. 1H NMR δ: 2.08-2.19 (m, 1H, =CCH2), 2.67 (ddd, J = 
15.6, 6.6, 2.1 Hz, 1H, =CCH2), 3.10 (br s, 1H, NH), 3.11 (td, J = 8.2, 
2.1 Hz, 1H, CH2CHC=O), 3.41-3.52 (m, 2H, NCHCHC=O and 
NCHCH=), 3.80 (s, 3H, OCH3), 3.87 (d, J = 12.8 Hz, 1H, 
CHNCH2Ar), 3.99 (d, J = 12.8 Hz, 1H, CHNCH2Ar), 4.56 (s, 2H, 
O=CNCH2Ar), 5.75-5.87 (m, 1H, NCHCH=CH), 5.93 (dt, J = 9.5, 
3.0 Hz, 1H, NCHCH=), 6.84-7.00 (m, 4H, ArH), 7.24-7.35 (m, 4H, 
ArH). 13C NMR δ: 24.2 (=CCH2), 39.3, 41.8 (2xCHC=O), 42.0 
(O=CNCH2Ar), 51.4 (CHNCH2Ar), 53.3 (NCHCH=), 55.4 (OCH3), 
114.1 (ArC), 115.5 (d, 2JC-F = 21.7 Hz, CHCF), 127.5, 129.8 (ArC, 
C=C), 130.4 (d, 3JC-F = 8.2 Hz, CHCHCF), 131.6 (d, 
4JC-F = 3.2 Hz, 
CCHCHCF), 133.0, 140.3, 159.1 (ArC), 162.4 (d, 1JC-F = 246.5 Hz, 
CF), 177.9, 179.5 (2xC=O). 19F NMR δ: -114.2. MS (EI) m/z: 394 
(M+, 2%), 136 (100), 121 (85), 109 (15). HRMS calculated for 




1,3(2H)-dione (6i): dark yellow sticky oil (56.6 mg, 56% yield). IR 
(neat) max: 1688, 1611, 1512, 1437, 1384, 1285, 1246, 1177, 1112, 
1031, 909, 757, 729 cm-1. 1H NMR δ: 2.07-2.14 (m, 1H, 
CH2CH2CH), 2.22 (qd, J = 12.5, 3.5 Hz, 1H, CH2CH2CH), 2.56-2.68 
(m, 2H, CH2CH2CH and CH2CH2CH), 2.78 (dt, J = 15.1, 4.1 Hz, 1H, 
CH2CH2CH), 2.83 (s, 3H, NCH3), 3.21 (t, J = 7.7 Hz, 1H, 
CH2CHCHC=O), 3.60-3.67 (m, 2H, NCHCHC=O and NCHCH=), 
3.78 (br s, 1H, NH), 3.79 (s, 3H, OCH3), 4.05 (d, J = 12.8 Hz, 1H, 
NCH2Ar), 4.12 (d, J = 12.8 Hz, 1H, NCH2Ar), 6.37 (br s, 1H, 
NCHCH=), 6.85-6.90 (m, 2H, ArH), 7.07-7.16 (m, 3H, ArH), 7.21-
7.25 (m, 1H, ArH), 7.39-7.44 (m, 2H, ArH). 13C NMR δ: 24.2 
(CCH2CH2), 24.9 (NCH3), 29.9 (CCH2CH2), 36.5 (CH2CHCHC=O), 
43.0, 43.4 (2xCHC=O), 50.6 (NCH2Ar), 54.3 (NCHCH=), 55.4 
(OCH3), 114.2, 123.7, 126.7, 127.8, 128.4, 129.7, 130.1, 130.7, 
133.0, 137.4, 138.2, 159.3 (ArC, C=C), 177.0, 178.3 (2xC=O). MS 
(EI) m/z: 402 (M+, 5%), 291 (10), 170 (42), 136 (57), 121 (100). 
HRMS calculated for C25H26N2O3: 402.1943; found: 402.1943. 
 
4.2.10. (3aS,4R,7aS)-2-Phenyl-4-{[(R)-1-phenylethyl]amino}-
3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6j): light brown 
needles (45.9 mg, 53% yield), mp 135-136 °C (Et2O), [α]
 = +96.4 
(c 1.1, CHCl3), IR (neat) max: 1705, 1490, 1447, 1386, 1264, 1173, 
1070, 1032, 734, 703 cm-1. 1H NMR δ: 1.46 (d, J = 6.5 Hz, 3H, 
CHCH3), 2.08 (ddt, J = 15.7, 8.1, 2.6 Hz, 1H, =CHCH2), 2.72 (ddd, J 
= 15.7, 6.7, 1.9 Hz, 1H, =CHCH2), 3.21 (td, J = 8.1, 1.9 Hz, 1H, 
CH2CHC=O), 3.42 (dt, J = 6.4, 2.8 Hz, 1H, NCHCH=), 3.62 (dd, J = 
9.5, 6.3 Hz, 1H, NCHCHC=O), 4.26 (q, J = 6.5 Hz, 1H, CHCH3), 
5.90 (ddt, J = 9.6, 6.5, 2.9 Hz, 1H, =CHCH2), 5.96 (dt, J = 9.6, 2.9 
Hz, 1H, NCHCH=), 7.18-7.48 (m, 10H, ArH), (NH not observed). 
13C NMR δ: 24.3 (CH2), 24.6 (NCHCH3), 39.3, 40.8 (2xCHC=O), 
52.0 (NCHCH=), 55.8 (NCHCH3), 126.6, 127.1, 127.3, 127.7, 128.8, 
128.9, 129.3, 131.8 (ArC, C=C), 177.5, 178.9 (2xC=O). MS (EI) 
m/z: 346 (M+, <1%), 331 (14), 173 (43), 120 (100), 106 (27), 105 
(72), 79 (28), 77 (20), 69 (26). HRMS calculated for C22H22N2O2: 




yellow sticky oil (30.1 mg, 30% yield), [α]
 = +98.6 (c 1.0, CHCl3). 
IR (neat) max: 1702, 1498, 1380, 1242, 1176, 1045, 749, 692 cm
-1. 
1H NMR δ: 1.51 (d, J = 6.5 Hz, 3H, CHCH3), 2.00 (ddt, J = 15.9, 
8.0, 3.0 Hz, 1H, =CHCH2), 2.68 (ddd, J = 15.7, 6.9, 2.0 Hz, 1H, 
=CHCH2), 3.15 (ddd, J = 9.3, 8.0, 1.9 Hz, 1H, CH2CHC=O), 3.39 
(dt, J = 6.2, 2.6 Hz, 1H, NCHCH=), 3.60 (dd, J = 9.1, 6.2 Hz, 1H, 
NCHCHC=O), 4.42 (q, J = 6.5 Hz, 1H, CHCH3), 5.87 (ddt, J = 9.6, 
6.5, 3.1 Hz, 1H, =CHCH2), 5.96 (dt, J = 9.3, 3.1 Hz, 1H, NCHCH=), 
7.18-7.89 (m, 12H, ArH) (NH not observed). 13C NMR δ: 24.3 
(=CHCH2), 24.9 (CH3), 39.3, 40.7 (2xCHC=O), 52.0 (NCHCH=), 
55.7 (NCHCH3), 123.1, 125.1, 125.9, 126.2, 126.6, 127.1, 127.8, 
128.7, 128.8, 129.3, 131.8, 133.1, 133.5, 138.9 (ArC, C=C), 177.4, 
179.0 (2xC=O). MS (EI) m/z: 396 (M+, 2%), 381 (17), 223 (15), 171 
(13), 170 (96), 156 (36), 155 (100), 154 (14), 153 (15), 129 (11), 79 




yellow plates (28.1 mg, 28% yield), mp 113-115 °C, [α]
 = -34.3 (c 
1.0, CHCl3). IR (neat) max: 1702, 1498, 1382, 1180, 861, 822, 750, 
692 cm-1. 1H NMR δ: 1.60 (d, J = 6.7 Hz, 3H, CHCH3), 2.01-2.11 
(m, 1H, =CHCH2), 2.67 (ddd, J = 15.8, 6.8, 1.9 Hz, 1H, =CHCH2), 
3.17 (td, J = 8.7, 1.9 Hz, 1H, CH2CHC=O), 3.39-3.44 (m, 1H, 
NCHCHC=O), 3.52 (br s, 1H, NCHCH=), 4.32 (q, J = 6.7 Hz, 1H, 
CHCH3), 5.93-6.00 (m, 1H, =CHCH2), 6.21 (dt, J = 9.7, 3.1 Hz, 1H, 
NCHCH=), 7.17-7.88 (m, 12H, ArH) (NH not observed). 13C NMR 
δ: 23.9 (CH3), 24.4 (=CHCH2), 39.3, 43.4 (2xCHC=O), 51.8 
(NCHCH=), 56.5 (NCHCH3), 125.3, 126.1, 126.3, 126.6, 126.9, 
127.8, 128.0, 128.8, 128.9, 129.3, 131.7, 133.2, 133.5 (ArC, C=C), 
178.1, 178.8 (2xC=O). MS (EI) m/z: 396 (M+, 2%), 381 (14), 223 


















3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6l): pale brown 
prisms (47.0 mg, 52% yield), mp 65-67 °C, [α]
	 = +43.3 (c 1.0, 
CHCl3). IR (neat) max: 1690, 1496, 1452, 1390, 1362, 1222, 1190, 
1106, 1025, 910, 733, 697 cm-1. 1H NMR δ (mixture of two 
rotamers): 1.73 (d, J = 7.3 Hz, 3H, CH3), 2.05-2.16 (m, 1H, 
=CHCH2), 2.61, 2.67 (2ddd, J = 15.6, 6.7, 2.1 Hz, 1H, =CHCH2, two 
rotamers), 3.03 (td, J = 8.2, 2.1 Hz, 1H, CH2CHC=O), 3.37, 3.38 
(2dd, J = 8.8, 6.0 Hz, 1H, NCHCHC=O, two rotamers), 3.44 (br s, 
1H, NH), 3.46-3.50 (m, 1H, NCHCH=), 3.90, 3.93 (2d, J = 13.1 Hz, 
1H, NCH2Ph, two rotamers), 4.02, 4.05 (2d, J = 13.1 Hz, 1H, 
NCH2Ph, two rotamers), 5.36, 5.37 (2q, J = 7.3 Hz, 1H, CHCH3, two 
rotamers), 5.78-5.89 (2m, 1H, =CH H2, two rotamers), 5.92, 5.98 
(dt, J = 9.5, 3.0 Hz, 1H, NCHCH=, two rotamers), 7.22-7.43 (m, 
10H, ArH). 13C NMR δ: 16.7 (CH3), 24.3 (=CHCH2), 39.0, 41.6 
(2xCHC=O), 50.2 (NCHCH3), 51.2 (NCH2Ph), 53.6 (NCHCH=), 
127.2, 127.3, 127.4, 127.7, 128.4, 128.5, 128.6, 133.0, 138.9, 139.5 
(ArC, C=C), 178.0, 179.7 (2xC=O). MS (EI) m/z: 360 (M+, 1%), 159 
(21), 144 (22), 106 (100), 105 (16), 91 (50). HRMS calculated for 
C23H24N2O2: 360.1838; found: 360.1827. 
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